Safety and tolerability of switching to asenapine from other antipsychotic agents: pooled results from two randomized multicenter trials in stable patients with persistent negative symptoms in schizophrenia

BACKGROUND: In clinical practice, clinicians often need to switch antipsychotic medications in patients with schizophrenia to optimize treatment outcomes. Here, we describe the safety and tolerability of switching existing antipsychotic treatments to asenapine or olanzapine monotherapy using various...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Cazorla, Pilar, Mackle, Mary, Zhao, Jun, Ha, Xianwei, Szegedi, Armin
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2012
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3383320/
https://ncbi.nlm.nih.gov/pubmed/22745558
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S29891
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares